NOVEL GLUCOSE LOWERING AGENTS ARE ASSOCIATED WITH A LOWER RISK OF CARDIOVASCULAR AND ADVERSE EVENTS IN TYPE 2 DIABETES: A POPULATION BASED ANALYSIS
Elharram, M., Moura, C., Abrahamowicz, M., Bernatsky, S., Behlouli, H., Raparelli, V., Pilote, L.Volume:
34
Language:
english
Journal:
Canadian Journal of Cardiology
DOI:
10.1016/j.cjca.2018.07.219
Date:
October, 2018
File:
PDF, 307 KB
english, 2018